The Joint Blog

JANUARY 23, 2020

Marijuana may be use “in the treatment of a range of psychiatric disorders”, according to a new study published in the journal BMC Psychiatry. The study is titled “Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

CannaMD

SEPTEMBER 28, 2020

Researchers are taking a new look at an ancient sleep treatment, Cannabis sativa , a plant long used to induce slumber. These represent the two most often studied cannabinoids overall, and sleep research is no different. Both cannabinoids have been studied separately for their abilities. Is there a more natural remedy?

Sleep 72

Sleep Clinical Trials Patients THC 72

Veriheal

APRIL 11, 2022

We could potentially develop north of 11,000 drugs that are cannabinoid-based. In particular, of all the components contained in the cannabis plant— including cannabinoids , terpenes , and flavonoids — the cannabis compound tetrahydrocannabinol (THC) has proven to harbor medicinal benefits when used in specific formulations.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. Preclinical studies involve exposing cells and animals to treatments to see if there are indications that the treatment could be worth evaluating in humans.

Research and Development 108

Research and Development Data THC Clinical Trials 108

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Canna Care Docs

JUNE 22, 2018

While cannabis has been used for medical, religious, and recreational purposes for over 5,000 years (1) , THC, as an isolated cannabinoid derived from the plant was first discovered by Raphael Mechoulam and Yechiel Goani in 1964 (2). Cannabinoid pharmacology: the first 66 years. Works Cited. Pertwee RG. British Journal of Pharmacology.

THC 66

THC Patients Blood Pressure Clinical Trials 66

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.

CBD 99

CBD DEA Research and Development Hemp 99

The Cannigma

JUNE 24, 2021

While more human clinical trials are needed, the current evidence suggests there may be potential therapeutic benefits for the following ailments: Chronic pain — the most common reason people turn to medical cannabis in the United States today. Cannabinoids may ease nausea and vomiting.

CBD 75

CBD Microdosing Edibles Sleep 75

Miss Marijuana

MAY 13, 2020

A Certificate of Analysis (COA) shows the product was made properly, does not contain pesticides or heavy metals (and verifies CBD content as well as other compounds, such as terpenes). Full spectrum means that the product contains most of the naturally occurring cannabinoids and terpenes of the plant. So which one works best?

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

Greencamp

AUGUST 16, 2018

Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. The first study I will reference is from 2006, conducted on mice.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Project CBD

OCTOBER 26, 2023

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Miss Marijuana

MAY 13, 2020

A Certificate of Analysis (COA) shows the product was made properly, does not contain pesticides or heavy metals (and verifies CBD content as well as other compounds, such as terpenes). Full spectrum means that the product contains most of the naturally occurring cannabinoids and terpenes of the plant. So which one works best?

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

CannaTech

SEPTEMBER 16, 2018

Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions. Cannabis medicine presents itself as an intimidating option despite patients requesting it as a form of treatment.

Education 66

Education Medicine Clinical Trials Patients 66

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Veriheal

SEPTEMBER 6, 2022

Recent research has found that terpene and cannabinoid profiles are far more significant when trying to produce specific effects. Recent research has found that certain cannabinoids may help with sleep. Terpene and cannabinoid profiles of the cannabis you are consuming will also impact the effects experienced.

Sleep 105

Sleep THC CBD Chronic Pain 105

Alchimia

JANUARY 25, 2022

Assuming clinical trials go well, the ultimate hope of the researchers is to develop a pill containing purified versions of these acidic cannabinoids as an adjunct to vaccination, for use after known exposure or by those who are immunocompromised. Why does CBD work best when combined with other cannabinoids and terpenes?

Research and Development 98

Research and Development Terpenes CBD Treatment 98

The Joint Blog

FEBRUARY 18, 2020

According to NORML, they reported that the use of medical cannabis, and in particular products dominant in the cannabinoid CBN (cannabinol), was associated with medication-sparing effects. The study is titled Cannabinoid and terpenoid doses are associated with adult ADHD status of medical cannabis patients.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

AUGUST 12, 2019

Today, modern science has identified a family of molecules known as cannabinoids as well as the human endocannabinoid system. Broad spectrum CBD oil contains a variety of active compounds such as cannabinoids and terpenes, which we will discuss in greater detail in Section 2. Purified cannabinoids are colorless and odorless.

CBD 40

CBD Terpenes Oil Tincture 40

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

NOVEMBER 7, 2019

The delivery of high quality and consistent medicinal products is key to providing good treatment outcomes for patients around the world and ensuring Good Manufacturing Practice (GMP) is paramount for treatment efficacy. Cannatrek is actively working on clinical trial protocols with a dedicated focus on mental health.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. MSO: Yeah, it’s very different.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). years (Atakan 2012 ). Discussion.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

JULY 20, 2021

With this method, you’ll be looking at the most dominant cannabinoids and terpenes in a given cannabis plant, and will choose your cannabis based on their known properties. Best terpenes for sex. After choosing your preferred chemotype, the next step involves deciding which terpenes are best for you. Depression.

Strains 145

Strains Terpenes Concentrates THC 145

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/rosalind-watts-89527660/.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49